Imaging the D 3 dopamine receptor across behavioral and drug addictions: Positron emission tomography studies

Chronic drug use has been associated with dopaminergic abnormalities, detectable in humans with positron emission tomography (PET). Among these, a hallmark feature is low D2 dopamine receptor availability, which has been linked to clinical outcomes, but has not yet translated into a therapeutic strategy. The D3 dopamine receptor on the other hand has gained increasing attention, as, in contrast to D2, chronic exposure to drugs has been shown to up-regulate this receptor subtype in preclinical models of addiction—a phenomenon linked to dopamine system sensitization and drug-seeking. The present article summarizes the literature to date in humans, suggesting that the D3 receptor may indeed contribute to core features of addiction such as impulsiveness and cognitive impairment. A particularly useful tool in investigating this

[1]  P. Sokoloff,et al.  A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning , 2005, Neuroreport.

[2]  E. Bullmore,et al.  Effect of the dopamine D3 receptor antagonist GSK598809 on brain responses to rewarding food images in overweight and obese binge eaters , 2012, Appetite.

[3]  J S Fowler,et al.  Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. , 2001, The American journal of psychiatry.

[4]  Alan A. Wilson,et al.  In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [11C]-(+)-PHNO , 2014, Molecular Psychiatry.

[5]  Sylvain Houle,et al.  Heightened D3 Dopamine Receptor Levels in Cocaine Dependence and Contributions to the Addiction Behavioral Phenotype: A Positron Emission Tomography Study with [11C]-(+)-PHNO , 2014, Neuropsychopharmacology.

[6]  P. Sokoloff,et al.  Dopamine D3 Receptors Expressed by All Mesencephalic Dopamine Neurons , 2000, The Journal of Neuroscience.

[7]  M. Martres,et al.  Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[8]  C. Heidbreder.  Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence. , 2008, CNS & neurological disorders drug targets.

[9]  David J. Nutt,et al.  Striatal dopamine D2/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity , 2012, NeuroImage.

[10]  A. Newman,et al.  Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders , 2010, Annals of the New York Academy of Sciences.

[11]  R. Narendran,et al.  Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]‐(+)‐PHNO is a D3 receptor preferring agonist in vivo , 2006, Synapse.

[12]  P. Cumming,et al.  Biodistribution studies of two 18F-labeled pyridinylphenyl amides as subtype selective radioligands for the dopamine D3 receptor. , 2014, Nuclear medicine and biology.

[13]  I. Lucki,et al.  Quantitative autoradiographic mapping of rat brain dopamine D3 binding with [(125)I]7-OH-PIPAT: evidence for the presence of D3 receptors on dopaminergic and nondopaminergic cell bodies and terminals. , 2000, The Journal of pharmacology and experimental therapeutics.

[14]  M. Martres,et al.  Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain , 1995, Neuroscience.

[15]  Robert Plomin,et al.  Dopamine markers and general cognitive ability , 1998, Neuroreport.

[16]  Richard E Carson,et al.  Affinity and selectivity of [11C]‐(+)‐PHNO for the D3 and D2 receptors in the rhesus monkey brain in vivo , 2012, Synapse.

[17]  N. Richtand.  Behavioral Sensitization, Alternative Splicing, and D3 Dopamine Receptor-Mediated Inhibitory Function , 2006, Neuropsychopharmacology.

[18]  B. Foll,et al.  Neuronal circuitry underlying the impact of D3 receptor ligands in drug addiction , 2015, European Neuropsychopharmacology.

[19]  M. Millan,et al.  Activation of dopamine D3 autoreceptors inhibits firing of ventral tegmental dopaminergic neurones in vivo. , 1995, European journal of pharmacology.

[20]  D. Mash,et al.  D3 Dopamine and Kappa Opioid Receptor Alterations in Human Brain of Cocaine‐overdose Victims , 1999, Annals of the New York Academy of Sciences.

[21]  M. Nader,et al.  Effects of Oral and Intravenous Administration of Buspirone on Food–Cocaine Choice in Socially Housed Male Cynomolgus Monkeys , 2015, Neuropsychopharmacology.

[22]  I. Boileau,et al.  Repurposing buspirone for drug addiction treatment. , 2013, The international journal of neuropsychopharmacology.

[23]  Sylvain Houle,et al.  [11C]‐(+)‐PHNO PET imaging of dopamine D2/3 receptors in Parkinson's disease with impulse control disorders , 2015, Movement disorders : official journal of the Movement Disorder Society.

[24]  Tiffany E. Chow,et al.  The potential role of dopamine D3 receptor neurotransmission in cognition , 2013, European Neuropsychopharmacology.

[25]  Yiyun Huang,et al.  Cocaine Dependence and D2 Receptor Availability in the Functional Subdivisions of the Striatum: Relationship with Cocaine-Seeking Behavior , 2004, Neuropsychopharmacology.

[26]  R. Carson,et al.  Dopamine D₃ receptor alterations in cocaine-dependent humans imaged with [¹¹C](+)PHNO. , 2014, Drug and alcohol dependence.

[27]  Sylvain Houle,et al.  Binding characteristics and sensitivity to endogenous dopamine of [11C]‐(+)‐PHNO, a new agonist radiotracer for imaging the high‐affinity state of D2 receptors in vivo using positron emission tomography , 2006, Journal of neurochemistry.

[28]  M. Knowles,et al.  Expression and pharmacological characterization of the human D3 dopamine receptor. , 1994, The Journal of pharmacology and experimental therapeutics.

[29]  S. Kapur,et al.  First demonstration of D3 occupancy in humans blockade of [C-11]-(+)-PHNO PET by ABT-925 , 2008 .

[30]  H. de Wit,et al.  Effects of Low to Moderate Acute Doses of Pramipexole on Impulsivity and Cognition in Healthy Volunteers , 2008, Journal of clinical psychopharmacology.

[31]  D. Mash,et al.  Adaptive Increase in D3 Dopamine Receptors in the Brain Reward Circuits of Human Cocaine Fatalities , 1996, The Journal of Neuroscience.

[32]  M. Galloway,et al.  Dopamine autoreceptor reserve in vitro: possible role of dopamine D3 receptors. , 1996, European journal of pharmacology.

[33]  M. Slifstein,et al.  Deficits in Dopamine D2 Receptors and Presynaptic Dopamine in Heroin Dependence: Commonalities and Differences with Other Types of Addiction , 2012, Biological Psychiatry.

[34]  M. Mandelkern,et al.  Low striatal dopamine receptor availability linked to caloric intake during abstinence from chronic methamphetamine abuse , 2012, Molecular Psychiatry.

[35]  John D. Beaver,et al.  Imaging Dopamine D3 Receptors in the Human Brain with Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist , 2010, Biological Psychiatry.

[36]  E. Rabiner,et al.  Occupancy of Brain Dopamine D3 Receptors and Drug Craving: A Translational Approach , 2013, Neuropsychopharmacology.

[37]  D. Mantini,et al.  UC Irvine UC Irvine Previously Published Works Title Combination Training in Aging Individuals Modifies Functional Connectivity and Cognition , and Is Potentially Affected by Dopamine-Related Genes , 2012 .

[38]  P. Sokoloff,et al.  Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Svante B. Ross,et al.  Synaptic Concentration of Dopamine in the Mouse Striatum in Relationship to the Kinetic Properties of the Dopamine Receptors and Uptake Mechanism , 1991, Journal of neurochemistry.

[40]  M. Martres,et al.  Localization and function of the D3 dopamine receptor. , 1992, Arzneimittel-Forschung.

[41]  Thomas E. Nichols,et al.  Orbitofrontal connectivity with resting-state networks is associated with midbrain dopamine D3 receptor availability. , 2012, Cerebral cortex.

[42]  Sylvain Houle,et al.  Radiosynthesis and evaluation of [11C]-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol as a potential radiotracer for in vivo imaging of the dopamine D2 high-affinity state with positron emission tomography. , 2005, Journal of medicinal chemistry.

[43]  E. Bullmore,et al.  The effects of the dopamine D₃ receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects. , 2012, The international journal of neuropsychopharmacology.

[44]  Roshan Cools,et al.  Role of Dopamine in the Motivational and Cognitive Control of Behavior , 2008, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[45]  S. Floresco,et al.  Mesocortical dopamine modulation of executive functions: beyond working memory , 2006, Psychopharmacology.

[46]  F. Limosin,et al.  Association between dopamine receptor D3 gene BalI polymorphism and cognitive impulsiveness in alcohol-dependent men , 2005, European Psychiatry.

[47]  Mark Slifstein,et al.  Alcohol Dependence Is Associated with Blunted Dopamine Transmission in the Ventral Striatum , 2005, Biological Psychiatry.

[48]  Zhen Yan,et al.  D3 Dopamine Autoreceptors Do Not Activate G-Protein-Gated Inwardly Rectifying Potassium Channel Currents in Substantia Nigra Dopamine Neurons , 2003, The Journal of Neuroscience.

[49]  K. Berridge,et al.  The neural basis of drug craving: An incentive-sensitization theory of addiction , 1993, Brain Research Reviews.

[50]  Bruno Giros,et al.  Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA , 1991, Brain Research.

[51]  Trevor W Robbins,et al.  Investigating the neurocognitive deficits associated with chronic drug misuse , 2001, Current Opinion in Neurobiology.

[52]  Alan A. Wilson,et al.  The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. , 2013, Addiction.

[53]  B. Quednow,et al.  Cognitive Impairment in Cocaine Users is Drug-Induced but Partially Reversible: Evidence from a Longitudinal Study , 2014, Neuropsychopharmacology.

[54]  Mark Slifstein,et al.  Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment. , 2011, The American journal of psychiatry.

[55]  B. Hoebel,et al.  Elevated D3 dopamine receptor mRNA in dopaminergic and dopaminoceptive regions of the rat brain in response to morphine. , 2003, Brain research. Molecular brain research.

[56]  I. Grant,et al.  Dopamine receptor D3 genetic polymorphism (rs6280TC) is associated with rates of cognitive impairment in methamphetamine-dependent men with HIV: preliminary findings , 2011, Journal of NeuroVirology.

[57]  Magnus Dahlbom,et al.  Striatal Dopamine D2/D3 Receptor Availability Is Reduced in Methamphetamine Dependence and Is Linked to Impulsivity , 2009, The Journal of Neuroscience.

[58]  J. Joyce,et al.  Distribution of Dopamine D3 Receptor Expressing Neurons in the Human Forebrain: Comparison with D2 Receptor Expressing Neurons , 1999, Neuropsychopharmacology.

[59]  D. Sibley,et al.  Medication discovery for addiction: translating the dopamine D3 receptor hypothesis. , 2012, Biochemical pharmacology.

[60]  A. Levey,et al.  Striatal dopamine nerve terminal markers in human, chronic methamphetamine users , 1996, Nature Medicine.

[61]  P. Kalivas,et al.  Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[62]  B. Gulyás,et al.  Lack of effect of reserpine-induced dopamine depletion on the binding of the dopamine-D3 selective radioligand, [11C]RGH-1756 , 2005, Brain Research Bulletin.

[63]  P. Sokoloff,et al.  Involvement of the direct striatonigral pathway in levodopa‐induced sensitization in 6‐hydroxydopamine‐lesioned rats , 2000, The European journal of neuroscience.

[64]  P. Sokoloff,et al.  Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats , 2003, Synapse.

[65]  T. J. Moore,et al.  Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. , 2014, JAMA internal medicine.

[66]  M. Nader,et al.  Abstinence from Chronic Cocaine Self-Administration Alters Striatal Dopamine Systems in Rhesus Monkeys , 2009, Neuropsychopharmacology.

[67]  Hans-Georg Buchholz,et al.  Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse. , 2008, The American journal of psychiatry.

[68]  J. Monterosso,et al.  Effect of Modafinil on Learning and Task-Related Brain Activity in Methamphetamine-Dependent and Healthy Individuals , 2011, Neuropsychopharmacology.

[69]  D. Sibley,et al.  Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors. , 2013, The international journal of neuropsychopharmacology.

[70]  E. London,et al.  Dopamine D3 receptors as a therapeutic target for methamphetamine dependence , 2014, The American journal of drug and alcohol abuse.

[71]  B. Levant.  The D3 dopamine receptor: neurobiology and potential clinical relevance. , 1997, Pharmacological reviews.

[72]  M. Mintun,et al.  [3H]4‐(Dimethylamino)‐N‐[4‐(4‐(2‐methoxyphenyl)piperazin‐ 1‐yl)butyl]benzamide, a selective radioligand for dopamine D3 receptors. I. In vitro characterization , 2009, Synapse.

[73]  Yiyun Huang,et al.  Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part 3: Radiosynthesis and in vivo studies. , 2009, Bioorganic & medicinal chemistry letters.

[74]  D. Nutt,et al.  In Vivo Imaging of Cerebral Dopamine D3 Receptors in Alcoholism , 2014, Neuropsychopharmacology.

[75]  B. Bloch,et al.  Expression of the d3 dopamine receptor in peptidergic neurons of the nucleus accumbens: Comparison with the D1 and D2 dopamine receptors , 1996, Neuroscience.

[76]  E. Bézard,et al.  The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders. , 2006, CNS & neurological disorders drug targets.

[77]  J. Kebabian,et al.  S-(+)-aporphines are not selective for human D3 dopamine receptors , 1994, Cellular and Molecular Neurobiology.

[78]  J. Hagan,et al.  The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence , 2005, Brain Research Reviews.

[79]  D. Mash,et al.  Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities. , 1997, Brain research. Molecular brain research.

[80]  Diana Martinez,et al.  Cocaine abuse and sensitization of striatal dopamine transmission: A critical review of the preclinical and clinical imaging literature , 2008, Synapse.

[81]  G. Gross,et al.  Dopamine D3 receptor antagonism—still a therapeutic option for the treatment of schizophrenia , 2012, Naunyn-Schmiedeberg's Archives of Pharmacology.

[82]  F. Paille,et al.  Cognitive Impairments in Alcohol-Dependent Subjects , 2014, Front. Psychiatry.

[83]  D. Zald,et al.  Dopaminergic Network Differences in Human Impulsivity , 2010, Science.

[84]  P. Vezina,et al.  Conditioned cues and the expression of stimulant sensitization in animals and humans , 2009, Neuropharmacology.

[85]  N. Volkow,et al.  Effects of chronic cocaine abuse on postsynaptic dopamine receptors. , 1990, The American journal of psychiatry.

[86]  Nora D Volkow,et al.  Similarity Between Obesity and Drug Addiction as Assessed by Neurofunctional Imaging , 2004, Journal of addictive diseases.

[87]  N. Mello,et al.  Effects of Chronic Buspirone Treatment on Nicotine and Concurrent Nicotine+Cocaine Self-Administration , 2013, Neuropsychopharmacology.

[88]  Yue-Cune Chang,et al.  Prefrontal executive function and D1, D3, 5-HT2A and 5-HT6 receptor gene variations in healthy adults. , 2008, Journal of psychiatry & neuroscience : JPN.

[89]  H. Teulings,et al.  Handwriting analysis indicates spontaneous dyskinesias in neuroleptic naïve adolescents at high risk for psychosis. , 2013, Journal of visualized experiments : JoVE.

[90]  A. Zapata,et al.  Selective D3 receptor agonist effects of (+)-PD 128907 on dialysate dopamine at low doses , 2001, Neuropharmacology.

[91]  Mark Jenkinson,et al.  Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy , 2011, NeuroImage.

[92]  P. Sokoloff,et al.  The dopamine D3 receptor and drug dependence: Effects on reward or beyond? , 2005, Neuropharmacology.

[93]  E. Bullmore,et al.  Effect of dopamine D3 receptor antagonism on approach responses to food cues in overweight and obese individuals , 2012, Behavioural pharmacology.

[94]  Sylvain Houle,et al.  High-Affinity States of Human Brain Dopamine D2/3 Receptors Imaged by the Agonist [11C]-(+)-PHNO , 2006, Biological Psychiatry.

[95]  Julie C. Stout,et al.  Neurocognitive insights into substance abuse , 2005, Trends in Cognitive Sciences.

[96]  Alan A. Wilson,et al.  D3 and D2 components of ex vivo regional (+)-PHNO brain binding in wild-type and knock-out mice , 2007 .

[97]  N. Mello,et al.  Effects of Chronic Buspirone Treatment on Cocaine Self-Administration , 2013, Neuropsychopharmacology.

[98]  E. Nestler,et al.  The Mesolimbic Dopamine Reward Circuit in Depression , 2006, Biological Psychiatry.

[99]  R. A. Fuchs,et al.  Increases in Dopamine D3 Receptor Binding in Rats Receiving a Cocaine Challenge at Various Time Points after Cocaine Self-Administration: Implications for Cocaine-Seeking Behavior , 2004, Neuropsychopharmacology.

[100]  B. Knowlton,et al.  Learning and memory functions of the Basal Ganglia. , 2002, Annual review of neuroscience.

[101]  J. Tepper,et al.  Functional Roles of Dopamine D2 and D3Autoreceptors on Nigrostriatal Neurons Analyzed by Antisense KnockdownIn Vivo , 1997, The Journal of Neuroscience.

[102]  J. Joyce,et al.  Localization of dopamine D3 receptors to mesolimbic and D2 receptors to mesostriatal regions of human forebrain. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[103]  N. Volkow,et al.  Decreased dopamine activity predicts relapse in methamphetamine abusers , 2011, Molecular Psychiatry.

[104]  Alan A. Wilson,et al.  Ventral Striatum Binding of a Dopamine D2/3 Receptor Agonist But Not Antagonist Predicts Normal Body Mass Index , 2015, Biological Psychiatry.

[105]  In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis. , 1996, European journal of pharmacology.

[106]  Pingyuan Gong,et al.  Variants in COMT and DBH Influence on Response Inhibition Ability in Chinese Han Females , 2011, Cellular and Molecular Neurobiology.

[107]  Bruno Giros,et al.  Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics , 1990, Nature.

[108]  N. Volkow,et al.  Therapeutic doses of buspirone block D3 receptors in the living primate brain. , 2014, The international journal of neuropsychopharmacology.

[109]  M. Yücel,et al.  Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention. , 2007, Drug and alcohol review.

[110]  F. J. White,et al.  Alterations in Dopamine Release But Not Dopamine Autoreceptor Function in Dopamine D3 Receptor Mutant Mice , 1998, The Journal of Neuroscience.

[111]  Marc Laruelle,et al.  Within-Subject Comparison of [11C]-( + )-PHNO and [11C]raclopride Sensitivity to Acute Amphetamine Challenge in Healthy Humans , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[112]  Ji Hyun Ko,et al.  Dopamine‐agonists and impulsivity in Parkinson's disease: Impulsive choices vs. impulsive actions , 2014, Human brain mapping.